{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:45:10Z","timestamp":1773809110904,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["172052"],"award-info":[{"award-number":["172052"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jpba.2015.02.023","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T15:07:26Z","timestamp":1424358446000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Quantitation of pregabalin in dried blood spots and dried plasma spots by validated LC\u2013MS\/MS methods"],"prefix":"10.1016","volume":"109","author":[{"given":"Na\u0111a","family":"Kosti\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannis","family":"Dotsikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neboj\u0161a","family":"Jovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Stevanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An\u0111elija","family":"Malenovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Medenica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.02.023_bib0100","unstructured":"Lyrica \u2013 FDA Prescribing Information, Side Effects and Uses (2014) http:\/\/www.drugs.com\/pro\/lyrica.html (accessed 16.12.14)."},{"key":"10.1016\/j.jpba.2015.02.023_bib0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel \u03b12\u2013\u03b4(alpha2\u2013delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jpba.2015.02.023_bib0110","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00228-013-1578-5","article-title":"Pregabalin abuse among opiate addicted patients","volume":"69","author":"Grosshans","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.jpba.2015.02.023_bib0115","first-page":"108","article-title":"LC\u2013MS\u2013MS method for the determination of pregabalin in human plasma","volume":"4","author":"Uma","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.02.023_bib0120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4103\/0110-5558.72423","article-title":"Determination of pregabalin in human plasma by electrospray ionisation tandem mass spectroscopy","volume":"1","author":"Shah","year":"2010","journal-title":"J. Adv. Pharm. Tech. Res."},{"key":"10.1016\/j.jpba.2015.02.023_bib0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1365\/s10337-007-0440-2","article-title":"Determination of pregabalin in human plasma using LC\u2013MS\u2013MS","volume":"67","author":"Mandal","year":"2008","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2015.02.023_bib0130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1365\/s10337-007-0430-4","article-title":"LC\u2013MS\u2013MS determination of pregabalin in human plasma","volume":"66","author":"Vaidya","year":"2007","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2015.02.023_bib0135","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jat\/bkt081","article-title":"Pregabalin determination in hair by ultra-high-performance liquid chromatography\u2013tandem mass spectrometry","volume":"37","author":"Pauly","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2015.02.023_bib0140","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1016\/j.jchromb.2009.10.004","article-title":"Liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry method for the quantification of pregabalin in human plasma","volume":"877","author":"Nirogi","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.02.023_bib0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jat\/bku004","article-title":"Quantification of pregabalin using hydrophilic interaction HPLC-high-resolution MS in postmortem human samples: eighteen case reports","volume":"38","author":"Priez-Barallon","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2015.02.023_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.talanta.2013.04.082","article-title":"Effects of derivatization reagents consisting of n-alkyl chloroformate\/n-alcohol combinations in LC-ESI-MS\/MS analysis of zwitterionic antiepileptic drugs","volume":"116","author":"Kosti\u0107","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2015.02.023_bib0155","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4155\/bio.13.214","article-title":"Recent advances in the bioanalytical applications of dried matrix spotting for the analysis of drugs and their metabolites","volume":"5","author":"Zimmer","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2015.02.023_bib0160","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/ac8022839","article-title":"Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method","volume":"81","author":"Spooner","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2015.02.023_bib0165","unstructured":"Guideline on Validation of Bioanalytical Methods. European Medicines Agency (2009) http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf (accessed 16.12.14)."},{"key":"10.1016\/j.jpba.2015.02.023_bib0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jms.3236","article-title":"Stepwise optimization approach for improving LC\u2013MS\/MS analysis of zwitterionic antiepileptic drugs with implementation of experimental design","volume":"48","author":"Kosti\u0107","year":"2013","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2015.02.023_bib0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"Dreifuss","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpba.2015.02.023_bib0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.talanta.2013.04.027","article-title":"Fast LC\u2013MS\/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery","volume":"115","author":"Koster","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2015.02.023_bib0185","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jchromb.2011.03.017","article-title":"Determination of moxifloxacin in dried blood spots using LC\u2013MS\/MS and the impact of the hematocrit and blood volume","volume":"879","author":"Vu","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.02.023_bib0190","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0090-9556(25)07404-5","article-title":"Pharmacokinetics and metabolism of vigabatrin following a single oral dose of [14C]vigabatrin in healthy male volunteers","volume":"21","author":"Durham","year":"1993","journal-title":"Drug. Metab. Dispos."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515001193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515001193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:51:12Z","timestamp":1759999872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":19,"alternative-id":["S0731708515001193"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.02.023","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitation of pregabalin in dried blood spots and dried plasma spots by validated LC\u2013MS\/MS methods","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}